Avedro (AVDR) Reaches New 52-Week High at $14.20

Share on StockTwits

Avedro Inc (NASDAQ:AVDR) hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $14.20 and last traded at $14.00, with a volume of 8283 shares trading hands. The stock had previously closed at $13.36.

Several equities research analysts recently issued reports on AVDR shares. Bank of America started coverage on Avedro in a research note on Monday, March 11th. They issued a “buy” rating for the company. Cowen started coverage on Avedro in a research note on Monday, March 11th. They issued an “outperform” rating and a $20.00 price target for the company. JPMorgan Chase & Co. started coverage on Avedro in a research note on Monday, March 11th. They issued an “overweight” rating and a $16.00 price target for the company. Svb Leerink started coverage on Avedro in a research note on Monday, March 11th. They issued an “outperform” rating and a $20.00 price target for the company. Finally, Leerink Swann started coverage on Avedro in a research note on Monday, March 11th. They issued an “outperform” rating and a $20.00 price target for the company. Six analysts have rated the stock with a buy rating, The stock has a consensus rating of “Buy” and an average target price of $19.40.

In other Avedro news, Director Gilbert H. Kliman bought 25,000 shares of the business’s stock in a transaction on Tuesday, February 19th. The stock was purchased at an average cost of $14.00 per share, for a total transaction of $350,000.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

ILLEGAL ACTIVITY NOTICE: This story was reported by Ticker Report and is the property of of Ticker Report. If you are reading this story on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.tickerreport.com/banking-finance/4231441/avedro-avdr-reaches-new-52-week-high-at-14-20.html.

About Avedro (NASDAQ:AVDR)

Avedro, Inc, an ophthalmic pharmaceutical and medical device company, develops and commercializes products to treat ophthalmic disorders and conditions, primarily associated with corneal weakness. The company's Avedro Corneal Remodeling platform comprises KXL and Mosaic systems, which deliver ultraviolet A or UVA light, and a suite of single-use riboflavin drug formulations.

Recommended Story: Understanding Price to Earnings Ratio (PE)

Receive News & Ratings for Avedro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avedro and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Freyrchain  Price Reaches $0.0009 on Top Exchanges
Freyrchain Price Reaches $0.0009 on Top Exchanges
CDK Global Inc  Announces Quarterly Dividend of $0.15
CDK Global Inc Announces Quarterly Dividend of $0.15
Exosis  Price Reaches $0.75 on Top Exchanges
Exosis Price Reaches $0.75 on Top Exchanges
Spok Holdings Inc  Announces $0.13 Quarterly Dividend
Spok Holdings Inc Announces $0.13 Quarterly Dividend
Berenberg Bank Reiterates Sell Rating for Acacia Mining
Berenberg Bank Reiterates Sell Rating for Acacia Mining
Yield Shares High Income ETF Declares Monthly Dividend of $0.13
Yield Shares High Income ETF Declares Monthly Dividend of $0.13


© 2006-2019 Ticker Report